[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.247.249. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
June 1963

Vaccinial Keratitis Treated with IDU

Author Affiliations

USA; Phoenixville, Pa
Present address: 4314 W. Slauson Blvd., Los Angeles 43, (Dr. Sorenson).

Arch Ophthalmol. 1963;69(6):730-732. doi:10.1001/archopht.1963.00960040736009
Abstract

Vaccination against smallpox with a live attenuated virus has resulted in a variety of statistically minor but clinically unusual complications including reported cases of encephalitis, acute renal failure, glomerulonephritis, thrombocytopenic purpura, and vaccinial keratitis.1 The keratitis is considered a serious ocular complication2 in spite of reports which allude to its benignity when treated with a number of therapeutic agents including cortisone.3

Presented here is a single case of keratitis immediately associated with generalized vaccinia, thought to clinically represent vaccinial keratitis which was treated with 5-iodo-2′-deoxyuridine (IDU).*

Realizing that a single case might stand as apocryphal concerning the efficacy of treatment, we still feel that the unusual circumstances of the corneal disease and the course of the illness after IDU treatment are of significant interest.

Vaccinia is a laboratory virus evolved from cowpox or variola virus which is modified by animal passage through calves or rabbits and irreversibly

First Page Preview View Large
First page PDF preview
First page PDF preview
×